tiprankstipranks
InnoCan Pharma (TSE:INNO)
:INNO
Canadian Market
INNO
InnoCan Pharma
RESEARCH TOOLSreports

InnoCan Pharma (INNO) Stock News & Sentiment

22 Followers
Innocan Pharma Secures Additional Insider Debenture Ahead of Planned U.S. Offering
Premium
Company Announcements
Innocan Pharma Secures Additional Insider Debenture Ahead of Planned U.S. Offering
6d ago
Innocan Pharma Secures Additional Insider Debenture Financing Ahead of Planned U.S. Offering
Premium
Company Announcements
Innocan Pharma Secures Additional Insider Debenture Financing Ahead of Planned U.S. Offering
12d ago
Innocan Pharma Secures Insider Debenture Financing Ahead of Planned U.S. Listing
Premium
Company Announcements
Innocan Pharma Secures Insider Debenture Financing Ahead of Planned U.S. Listing
1M ago
Innocan’s Long-Acting CBD Injection Shows Superiority to Placebo in Canine Pain Trial
Premium
Company Announcements
Innocan’s Long-Acting CBD Injection Shows Superiority to Placebo in Canine Pain Trial
2M ago
Innocan Pharma Targets NYSE American Listing With Concurrent Offering
Premium
Company Announcements
Innocan Pharma Targets NYSE American Listing With Concurrent Offering
3M ago
Innocan Pharma Targets NYSE American Listing with Concurrent Securities Offering
Premium
Company Announcements
Innocan Pharma Targets NYSE American Listing with Concurrent Securities Offering
3M ago
Innocan Pharma Unveils Promising Advances in CBD Drug Delivery Platform
Premium
Company Announcements
Innocan Pharma Unveils Promising Advances in CBD Drug Delivery Platform
4M ago
More TSE:INNO News >

INNO News on the Web

Innocan Pharma Secures Additional Insider Debenture Ahead of Planned U.S. Offering
TipRanks News
Neutral
Innocan Pharma Secures Additional Insider Debenture Financing Ahead of Planned U.S. Offering
TipRanks News
Neutral
Innocan Pharma Secures Insider Debenture Financing Ahead of Planned U.S. Listing
TipRanks News
Neutral
Innocan’s Long-Acting CBD Injection Shows Superiority to Placebo in Canine Pain Trial
TipRanks News
Neutral
Innocan Pharma Targets NYSE American Listing With Concurrent Offering
TipRanks News
Neutral
Innocan Pharma To List On NYSE American With Concurrent Offering
rttnews
Neutral
Innocan Pharma Reports 2025 Financial Results
TipRanks News
Neutral
Innocan Pharma’s LPT-CBD Injections Transform Animal Care at Freedom Farm
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
TSE:INNO
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:INNO’s Media Buzz Sentiment?
1 articles about TSE:INNO were published this week. In an average week, 1 articles are published.
    What is TSE:INNO’s weekly average amount of articles?
    In an average week, 1 articles about TSE:INNO are published.
      What is TSE:INNO’s News Sentiment?
      50% of articles about TSE:INNO were positive this week, compared to its sector average of 58%.
        Consumer Defensive Stocks that are Trending in the News
        PXEDPhoenix Education Partners, Inc.
        SMPLSimply Good Foods
        NWCNorth West
        2918WARABEYA NICHIYO HOLDINGS Co., Ltd.
        8194Life Corporation
        Showing the stocks with the most bullish news sentiment over the past week